IDiyas

For the Inventor, By the Inventor

Moerkapelle, Netherlands

Cecilia Anna Wilhelmina Geuijen

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 39(Granted Patents)


Location History:

  • Moerkapelle, NL (2010 - 2013)
  • Utrecht, NL (2022 - 2023)

Company Filing History:

goldMedal7 out of 42 
 
Merus N.v.
 patents
silverMedal2 out of 146 
 
Crucell Holland B.v.
 patents
where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 12247078 - ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene (2025-03-11),
2. 12195551 - Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine therapy for breast cancer (2025-01-14),
3. 12139548 - Antibody that binds ErbB-2 and ErbB-3 (2024-11-12),
4. 11780925 - ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene (2023-10-10),
5. 11773170 - Antibodies that bind EGFR and cMET (2023-10-03),
6. 11753470 - Bispecific anti PD1-anti TIM3 antibodies (2023-09-12),
7. 11732043 - Antibodies that modulate a biological activity expressed by a cell (2023-08-22),
8. 11685786 - Binding molecules that bind CD137 and PD-L1 (2023-06-27),
9. 11667714 - Binding molecules that modulate a biological activity expressed by a cell (2023-06-06),
10. 11279770 - Antibody that binds ErbB-2 and ErbB-3 (2022-03-22),
11. 8551488 - Binding molecules for treatment and detection of cancer (2013-10-08),
12. 7858086 - Binding molecules for treatment and detection of cancer (2010-12-28),

Title: Cecilia Anna Wilhelmina Geuijen: Pioneering Innovations in Biomedical Science

Introduction: Cecilia Anna Wilhelmina Geuijen from Moerkapelle, NL, is a trailblazing inventor whose remarkable creativity and fearless pursuit of ideas have established her as a beacon of innovation within the scientific community.

Latest Patents: Cecilia holds an impressive portfolio of 7 patents, with her latest groundbreaking inventions focusing on bispecific antibodies targeting PD-1 and TIM-3 proteins, as well as antibodies modulating biological activities in cells. These inventions offer novel means to interfere with inhibitory pathways within cells, showcasing her expertise in biomedical research and therapeutic development.

Career Highlights: Throughout her career, Cecilia has made significant contributions to the field of biotechnology. She has worked with renowned companies such as Merus N.V. and Crucell Holland B.V., where her ingenuity and scientific acumen have led to the successful development of novel therapeutic strategies.

Collaborations: Collaboration plays a vital role in Cecilia's innovative endeavors. She has collaborated with esteemed colleagues, including Cornelis Adriaan De Kruif and Mark Throsby, to drive forward pioneering research projects and translate scientific discoveries into impactful inventions.

Conclusion: Cecilia Anna Wilhelmina Geuijen's unwavering dedication to pushing the boundaries of biomedical science and her passion for pioneering innovations serve as an inspiration to aspiring inventors worldwide. Her outstanding contributions continue to shape the landscape of biotechnology and pave the way for future breakthroughs in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…